Stryker director sells 12k shares, soon after Sage Products acquisition & potential Moody's downgrade: 7 points

Spinal Tech

Ronda E. Stryker, director at Stryker, sold 12,000 shares of the company's stock in a recent transaction, according to a Daily Political report.

Here are seven points:

 

1. The stock was sold at an average price of $99 per share, and the transaction totaled $1.18 million.

 

2. Ms. Stryker now directly owns 192,194 shares of the company's stock, valued at $19.02 million.

 

3. This transaction comes on the heels of Stryker's $2.7 billion acquisition of Sage Products. Moody's Investors Service placed Stryker's A3 unsecured note ratings on review for downgrade just last week.

 

4. In December 2015, Ms. Stryker sold 18,000 shares of the company following rumors that Stryker is once again planning to make a bid for Smith & Nephew.

 

5. Stryker has a 12-month low of $86.68 and a 12-month high of $105.34.

 

6. The company's 50-day moving average is $93.42, and its 200-day moving average is $96.75.

 

7. Stryker has a market cap of $36.27 billion.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers